Dividend Assets Capital LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,236 shares of the healthcare conglomerate’s stock after purchasing an additional 1,487 shares during the quarter. Dividend Assets Capital LLC’s holdings in UnitedHealth Group were worth $3,809,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. TCTC Holdings LLC raised its stake in shares of UnitedHealth Group by 10.5% during the 4th quarter. TCTC Holdings LLC now owns 13,700 shares of the healthcare conglomerate’s stock valued at $4,805,000 after purchasing an additional 1,303 shares during the period. AGF Investments Inc. increased its stake in UnitedHealth Group by 18.7% in the 4th quarter. AGF Investments Inc. now owns 518,475 shares of the healthcare conglomerate’s stock worth $181,819,000 after acquiring an additional 81,789 shares during the last quarter. Calamos Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 3.2% in the 1st quarter. Calamos Wealth Management LLC now owns 39,271 shares of the healthcare conglomerate’s stock worth $14,612,000 after purchasing an additional 1,207 shares in the last quarter. Trust Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 30.3% in the 4th quarter. Trust Asset Management LLC now owns 6,268 shares of the healthcare conglomerate’s stock worth $2,198,000 after purchasing an additional 1,458 shares in the last quarter. Finally, Lokken Investment Group LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $734,000. Institutional investors own 86.03% of the company’s stock.
NYSE:UNH traded up $1.64 on Tuesday, reaching $407.54. 25,155 shares of the company’s stock traded hands, compared to its average volume of 3,262,127. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.59. The stock has a 50-day simple moving average of $378.48 and a 200-day simple moving average of $349.25. The firm has a market cap of $384.67 billion, a PE ratio of 23.31, a P/E/G ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a 12 month low of $273.71 and a 12 month high of $406.77.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were issued a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.23%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.09%.
In other UnitedHealth Group news, EVP Patricia L. Lewis sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, April 16th. The stock was sold at an average price of $389.99, for a total transaction of $1,169,970.00. Following the sale, the executive vice president now directly owns 9,214 shares of the company’s stock, valued at $3,593,367.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 619 shares of the business’s stock in a transaction that occurred on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total value of $200,494.10. Following the sale, the chief accounting officer now directly owns 31,908 shares in the company, valued at $10,335,001.20. The disclosure for this sale can be found here. Insiders sold 20,420 shares of company stock worth $7,532,962 over the last ninety days. Insiders own 0.80% of the company’s stock.
Several equities research analysts recently weighed in on UNH shares. Credit Suisse Group increased their target price on UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, April 22nd. Barclays increased their price objective on UnitedHealth Group from $405.00 to $435.00 and gave the stock an “overweight” rating in a report on Thursday, April 22nd. Mizuho increased their price objective on UnitedHealth Group from $380.00 to $394.00 and gave the stock a “buy” rating in a report on Thursday, April 15th. Oppenheimer increased their price objective on UnitedHealth Group from $375.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, April 22nd. Finally, Bank of America reiterated a “buy” rating and issued a $415.00 price objective on shares of UnitedHealth Group in a report on Thursday, January 21st. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $409.61.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Recommended Story: What does a bar chart mean for investors?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.